EUVIMEDEUVIMED entdecken
Crossref

Inpatient Complication Rates of Bronchoscopic Lung Volume Reduction in the United States

Francisco F Costa Filho, Jonh D Buckley, Alan Furlan, Samantha Campbell, Kirsten Hickok, Philip J Kroth

CHEST · 2025

DOI: 10.1016/j.chest.2024.08.012 ↗

Kurz gefasst

Fachartikel in der Zeitschrift CHEST, 2025. Verfasst von Francisco F Costa Filho und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Western Michigan University Homer Stryker MD School of Medicine, Kalamazoo, MI. Electronic address: flavio.costafilh…. Hauptthemen laut MEDLINE: Bronchoscopy, Pulmonary Emphysema, Pneumonectomy, Postoperative Complications. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 21 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Early randomized controlled trials (RCTs) of bronchoscopic lung volume reduction (BLVR) have shown clinically meaningful benefits in lung function, dyspnea, and quality of life in patients with severe emphysema. Safety outcome data obtained after BLVR in the United States are scarce outside the RCTs. RESEARCH QUESTION: What is the rate of inpatient complications after BLVR in the real world in the United States? STUDY DESIGN AND METHODS: We used the National Inpatient Sample database to identify in-hospital complications after BLVR from 2018 through 2020. Complications were defined as pneumothorax, COPD exacerbation, pneumonia, hemoptysis, acute respiratory failure, and valve removal. We also analyzed all-cause in-hospital mortality and length of stay (LOS). RESULTS: We identified 467 admissions related to BLVR procedures. The number of procedures doubled between 2019 and 2020 (from 153 to 295 procedures). The median age was 67.9 years (interquartile range, 61.1-72.8 years), 210 patients (45.0%) were female, 401 patients (85.8%) were White, and Medicare was the primary expected payer for 72.8% of patients. Most procedures were performed in urban teaching hospitals (56.9%). The rate of pneumothorax was 26.3%, that of acute respiratory failure was 19.5%, that of COPD exacerbation was 8.8%, that of pneumonia was 7.3%, and that of hemoptysis was 5.3%. Chest tube placement was required in 84 of 123 patients (68.3%) with pneumothorax. The endobronchial valve had to be removed in 69 patients (14.8%). The median LOS was 2.8 days (interquartile range, 2.3-4.5 days). The number of in-hospital deaths was fewer than 11 (< 2.3%). Overall, the subgroup who experienced in-hospital complications did not differ significantly from the others in terms of comorbidities, demographics, and hospital characteristics. INTERPRETATION: We found that the real-world complication rate after BLVR was similar to the published complication rates from early randomized clinical trials. In-hospital mortality was low, suggesting that aside from the commonly anticipated complications, BLVR is a safe treatment option for severe emphysema.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BronchoscopyPulmonary EmphysemaPneumonectomyPostoperative ComplicationsHumansUnited StatesMaleFemaleAgedMiddle AgedHospital MortalityPneumothoraxLength of Stay

Stichwörter der Autor:innen

National Inpatient Sample databaseadvanced emphysemabronchoscopic lung volume reductioncomplicationsendobronchial valve

Autor:innen und Institutionen

  • Department of Internal Medicine, Western Michigan University Homer Stryker MD School of Medicine, Kalamazoo, MI. Electronic address: flavio.costafilho@wmed.edu.
  • Department of Internal Medicine, Western Michigan University Homer Stryker MD School of Medicine, Kalamazoo, MI.
  • Department of Biomedical Informatics, Western Michigan University Homer Stryker MD School of Medicine, Kalamazoo, MI.
  • Department of Internal Medicine, Western Michigan University Homer Stryker MD School of Medicine, Kalamazoo, MI; Department of Biomedical Informatics, Western Michigan University Homer Stryker MD School of Medicine, Kal…

Zitieren

APA

Costa Filho, F. F., Buckley, J. D., Furlan, A., Campbell, S., Hickok, K., & Kroth, P. J. (2025). Inpatient Complication Rates of Bronchoscopic Lung Volume Reduction in the United States. CHEST. https://doi.org/10.1016/j.chest.2024.08.012

Vancouver

Costa Filho FF, Buckley JD, Furlan A, Campbell S, Hickok K, Kroth PJ. Inpatient Complication Rates of Bronchoscopic Lung Volume Reduction in the United States. CHEST. 2025. doi:10.1016/j.chest.2024.08.012

BibTeX
@article{CostaFilho2025,
  author = {Costa Filho, Francisco F and Buckley, Jonh D and Furlan, Alan and Campbell, Samantha and Hickok, Kirsten and Kroth, Philip J},
  title = {Inpatient Complication Rates of Bronchoscopic Lung Volume Reduction in the United States},
  journal = {CHEST},
  year = {2025},
  doi = {10.1016/j.chest.2024.08.012}
}
Kostenlos starten →